Weight Loss as a Determinant of Histological Improvement in Metabolic Dysfunction-Associated Steatotic Liver Disease in People With Obesity.

Meta-analysis examining how weight loss from therapies including tirzepatide drives histological improvement in metabolic liver disease.

Effects of testosterone undecanoate as add-on therapy in obese hypogonadal men that are late responders to tirzepatide: a pilot study.

Pilot study investigating testosterone supplementation in obese men with poor initial response to tirzepatide.

Real-World Evidence of Tirzepatide in Indian Adults With Type 2 Diabetes: Significant Early Glycemic and Cardiometabolic Benefits.

Real-world study documenting tirzepatide's glycemic and cardiometabolic benefits in Indian adults with type 2 diabetes.

Beyond Weight Loss: Holistic Impacts of a Digital Weight Management Programme Integrating Tirzepatide.

Study evaluating holistic health outcomes beyond weight loss in a digital program integrating tirzepatide.

Annual pharmacy cost per patient achieving composite treatment endpoints: a cost to target analysis of tirzepatide versus subcutaneous semaglutide 1 mg.

Cost-effectiveness analysis comparing tirzepatide versus semaglutide for achieving treatment targets in type 2 diabetes.

Real-world data of tirzepatide in obesity management: a multicenter study by the Italian Society of Obesity.

Multicenter Italian real-world study evaluating tirzepatide's effectiveness in clinical obesity management.